Reproductive Health Care for HIV+ Young Women: What Should We Do?

Raymond Surya, Harry Prawiro Tantry, Dwiana Ocviyanti

Abstract

Introduction: This article aims to discuss reproductive health for young woman with positive HIV during postnatal care. Discussion: In HIV positive patients, ART treatment protocols may vary. Hormonal contraception in the form of combined oral contraception (COC), progestin-only pill, depo medroxyprogesteron acetate (DMPA), and implant are considered safe. Intrauterine device (IUD) is also safe for positive HIV women. Cervical cancer screening with Pap smear is performed at the initial diagnosis of HIV in patient less than 30 years of age. Summary: Antiretroviral therapy should be initiated early. HIV patients can safely use either hormonal contraception or IUD. Cervical cancer screening should be performed at the initial diagnosis of HIV.

Pendahuluan: Artikel ini mendiskusikan kesehatan reproduksi wanita muda HIV positif selama perawatan pascamelahirkan. Diskusi: Pada pasien positif HIV, protokol terapi antiretrovirus cukup bervariasi. Kontrasepsi hormonal dalam bentuk pil oral kombinasi (POK), pil berbasis progestin, depo medroksiprogesteron asetat (DMPA), dan implan aman untuk pasien HIV positif. Skrining kanker serviks dengan Pap smear sebaiknya dilakukan saat awal terdiagnosis HIV pada pasien usia <30 tahun. Simpulan: Terapi antiretrovirus sebaiknya dimulai sedini mungkin. Pasien HIV aman menggunakan kontrasepsi hormonal maupun spiral. Skrining kanker serviks sebaiknya dilakukan saat awal terdiagnosis HIV.

Full Text:

PDF

References

MoH. Report of situation analysis of HIVAIDS in 2018. MoH Jakarta; 2018.

Indonesia [Internet]. [cited 2021 Dec 8]. Available from: https://www.unaids.org/en/regionscountries/countries/indonesia

Najmah, Andajani S, Davies SG. Perceptions of and barriers to HIV testing of women in Indonesia. Sex Reprod Health Matters. 2020 Dec 17;28(2):1848003.

Muhaimin T, Besral B. HIV Prevalence among Pregnant Women in Eight Provincial Capitals in Indonesia in 2003-2010. Makara J Health Res. 2012 Mar 20;15(2):93–100.

Lubis DS, Wulandari LPL, Suariyani NLP, Adhi KT, Andajani S. Private Midwives’ Perceptions on Barriers and Enabling Factors to Voluntary Counselling and HIV Test (VCT) in Bali, Indonesia. Kesmas J Kesehat Masy Nas Natl Public Health J [Internet]. 2019 Aug 1 [cited 2021 Nov 18];14(1). Available from: https://journal.fkm.ui.ac.id/kesmas/article/view/2708

Alliance WR. Respectful maternity care. White Ribb Alliance Wash DC Univers Rights Childbear Women Wash. 2011;

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016 Jul 12;316(2):171–81.

Del Romero J, Baza MB, Río I, Jerónimo A, Vera M, Hernando V, et al. Natural conception in HIV-serodiscordant couples with the infected partner in suppressive antiretroviral therapy. Medicine (Baltimore). 2016 Jul 29;95(30):e4398.

Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. PLoS Med. 2016 Aug;13(8):e1002099.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015 Dec 1;61(11):1715–25.

Organization WH. Sexual and reproductive health of women living with HIV. AIDS. 2006;

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.

Tepper NK. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection. MMWR Morb Mortal Wkly Rep [Internet]. 2020 [cited 2021 Nov 18];69. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6914a3.htm

Liu G, Sharma M, Tan N, Barnabas R. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. AIDS Lond Engl. 2018 Mar 27;32(6):795–808.

Human Papillomavirus Disease | NIH [Internet]. [cited 2021 Nov 18]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/human-papillomavirus-disease

Refbacks

  • There are currently no refbacks.